周艷麗,張艷,李英琴,王愛(ài)莉,李碩熙,李博謙
(黑龍江中醫(yī)藥大學(xué) 佳木斯學(xué)院,黑龍江 佳木斯 154007)
周艷麗,張艷*,李英琴,王愛(ài)莉,李碩熙,李博謙
(黑龍江中醫(yī)藥大學(xué) 佳木斯學(xué)院,黑龍江 佳木斯 154007)
條葉龍膽Gentianamanshurica Kitag.屬于龍膽科龍膽屬(Gentiana)多年生草本植物,是黑龍江省地道藥材,其主要分布于松嫩平原西部,具清熱燥濕、瀉肝膽火之效[1]。近些年藥學(xué)工作者對(duì)龍膽屬植物的化學(xué)成分做了大量較為深入的研究,分離鑒定出多種成分,主要為黃酮、三萜、環(huán)烯醚萜及裂環(huán)環(huán)烯醚萜等類(lèi)成分[2]。臨床中龍膽經(jīng)常與其他中藥配伍用于治療濕疹[3]、帶狀皰疹[4]、多囊卵巢綜合征(PCOS)[5]、慢性盆腔炎[6]、列腺炎并弱精癥[7]、復(fù)發(fā)性口腔潰瘍[8]等伴隨炎癥反應(yīng)的病癥,可見(jiàn)龍膽具有良好的抗炎活性,但國(guó)內(nèi)外學(xué)者對(duì)其抗炎活性物質(zhì)基礎(chǔ)鮮有深入研究。
柱色譜硅膠(硅膠H,煙臺(tái)化學(xué)工業(yè)研究所);Sephadex LH-20 (25~100 μm,德國(guó)GE公司);Agilent 1100型高效液相色譜儀(美國(guó)安捷倫科技公司),C18反相柱填料 (250 mm×20 mm,5 μm,日本Nacalai Tesque公司) 色譜柱;RP-18 (50 μm,日本YMC公司);BRUKER AV400-III核磁共振儀(德國(guó)布魯克公司),溶劑峰為內(nèi)標(biāo);Agilent 6100質(zhì)譜儀(美國(guó)安捷倫科技公司)。
2014年7月在黑龍江省碾子山地區(qū)采集藥材10 kg,該藥材鑒定為龍膽科龍膽屬條葉龍膽G.manshuricaKitag的根及根莖,鑒定人為黑龍江中醫(yī)藥大學(xué)陳效忠副教授。
2.1 藥材的提取與分離
條葉龍膽G.manshuricaKitag的根及根莖共10.0 kg,用95%的乙醇水溶液(6 L)回流提取3次,每次1 h,提取液合并后經(jīng)真空干燥去除溶劑,得到干浸膏共4.0 kg。將浸膏加水混懸分散,然后分別用乙酸乙酯和正丁醇進(jìn)行萃取分段。乙酸乙酯萃取液經(jīng)真空濃縮干燥,得到乙酸乙酯萃取物500 g,該部分經(jīng)硅膠柱色譜初步分離,用石油醚-乙酸乙酯(90∶10~100∶0)系統(tǒng)進(jìn)行梯度洗脫,最后再用甲醇洗脫,共收集得到7個(gè)組分,分別為Fr.A~G。Fr.D (20.0 g)經(jīng)MCI柱色譜分離(洗脫劑為甲醇-水系統(tǒng),體積比10∶90~100∶0),進(jìn)一步分成7個(gè)亞組分Subfr.D1~D7。Subfr.D3先后經(jīng)C18反相柱色譜(甲醇-水,體積比為20∶80~90∶10)和LH-20凝膠柱色譜(甲醇洗脫)分離純化得到化合物1(8.0 mg)和9(12.5 mg)。Subfr.D4通過(guò)與Subfr.D3相同的分離手段和程序,分離純化得到了化合物4(18.0 mg)、5(22.5 g)和6(9.0 mg)。Subfr.D5先經(jīng)C18反相柱色譜(MeOH-H2O甲醇-水,體積比為20∶80~90∶10)初步分離,再用制備型HPLC進(jìn)行純化(流動(dòng)相為乙腈-水溶液,體積比40∶60)得到化合物3(10.0 mg)、7(16.6 mg)和10(12.6 mg)。Fr.E (30.2 g)經(jīng)C18反相柱色譜(甲醇-水,體積比為10∶90~100∶0)分離,獲得25個(gè)組分Fr.E1~E25。組分Fr.E7 (1.6 g)經(jīng)制備型HPLC(甲醇-水為流動(dòng)相,體積比為10∶90,流速為6.0 mL·min-1)分離獲得化合物2(10.0 mg)。組分Fr.E12 (1.6 g)經(jīng)制備型HPLC(甲醇-水為流動(dòng)相,體積比為40∶60,流速為6.0 mL·min-1)分離獲得化合物8(8.5 mg)。
2.2 抑制NO產(chǎn)生作用實(shí)驗(yàn)方法
將C57BL6/J小鼠的巨噬細(xì)胞以RPMI1640培養(yǎng)基培養(yǎng)在48孔細(xì)胞培養(yǎng)板中,37 ℃條件下,培養(yǎng)24 h。然后將細(xì)胞分為4組(全部生長(zhǎng)于RPMI1640培養(yǎng)基中):空白對(duì)照組(只加入RPMI1640培養(yǎng)基),脂多糖對(duì)照組(加入1 mg·mL-1的脂多糖),實(shí)驗(yàn)對(duì)照組(加入了1 mg·mL-1的脂多糖和候選化合物)和陽(yáng)性對(duì)照組(加入1026 mol·L-1[當(dāng)量]地塞米松)。將這些細(xì)胞在37 ℃條件下繼續(xù)培養(yǎng)24 h。在100 mL的上清液中分別加入等量的格里斯試劑,并用酶標(biāo)儀在波長(zhǎng)570 nm下進(jìn)行檢測(cè)。以亞硝酸鈉作為計(jì)算NO濃度的標(biāo)準(zhǔn)。
3.1 化合物結(jié)構(gòu)鑒定
化合物1:淡黃色粉末。ESI-MS:m/z653 [M+Na]+;1H-NMR (DMSO-d6,500 MHz)δ:5.17 (1H,dd,J=2.3 Hz,2.3 Hz,H-3),6.70 (1H,dd,J=10.3 Hz,2.3 Hz,H-4),6.03 (1H,dd,J=10.3 Hz,2.3 Hz,H-5),6.24 (1H,s,H-11),3.49 (3H,s,H-16),6.05 (1H,s,H-1′),6.93 (1H,s,H-3′),6.88 (1H,s,H-5′),5.09 (1H,d,J=6.9 Hz,H-11′),6.53 (1H,dd,J=8.1 Hz,6.9 Hz,H-12′),6.19 (1H,d,J=8.1 Hz,H-13′),2.96 (1H,d,J=18.4 Hz,H-15′a),2.65 (1H,d,J=18.4 Hz,H-15′b),2.36 (3H,s,H-16′),1.98 (3H,s,H-18′),8.14 (1H,s,7-OH),11.23 (1H,s,10-OH),11.50 (1H,s,6′-OH),13.95 (1H,v br s,8′-OH);13C-NMR (DMSO-d6,125 MHz)δ:90.8 (C-2),68.5 (C-3),145.8 (C-4),128.1 (C-5),188.4 (C-6),79.3 (C-7),191.8 (C-8),104.7 (C-9),159.8 (C-10),113.6 (C-11),148.6 (C-12),114.5 (C-13),154.2 (C-14),168.3 (C-15),53.1 (C-16),72.5 (C-1′),136.8 (C-2′),123.2 (C-3′),147.6 (C-4′),118.9 (C-5′),160.7 (C-6′),112.3 (C-7′),184.6 (C-8′),105.5 (C-9′),186.5 (C-10′),37.4 (C-11′),131.4 (C-12′),133.2 (C-13′),40.9 (C-14′),34.2 (C-15′),21.6 (C-16′),169.8 (C-17′),20.9 (C-18′)。以上數(shù)據(jù)與文獻(xiàn)報(bào)道的數(shù)據(jù)基本一致[9],故鑒定化合物1為acremoxanthone D。
化合物2:淡黃色粉末。ESI-MS:m/z451 [M+H]+;1H-NMR (DMSO-d6,500 MHz)δ:2.41 (3H,br s,H-1),6.93 (1H,dd,J=10.3 Hz,2.3 Hz,H-3),6.59 (1H,s,H-7),6.67 (1H,br s,H-15),3.95 (3H,s,8-OCH3),11.77 (1H,br s,6-OH),11.65 (1H,br s,14-OH),4.86 (1H,d,J=7.6 Hz,H-1′),3.35 (1H,overlapped,H-2′),3.25 (1H,td,J=8.6 Hz,4.8Hz,H-3′),3.18 (1H,m,H-4′),3.11 (1H,ddd,J=9.6 Hz,5.8 Hz,1.8 Hz,H-5′),3.62 (1H,ddd,J=11.6 Hz,5.6 Hz,1.8 Hz,H-6′a),3.40 (1H,ddd,J=11.6 Hz,5.8 Hz,5.6 Hz,H-6′b),5.15 (1H,d,J=4.9 Hz,2′-OH),5.03 (1H,d,J=4.8 Hz,3′-OH),4.95 (1H,d,J=5.1 Hz,4′-OH),4.28 (1H,t,J=5.6 Hz,6′-OH);13C-NMR (DMSO-d6,125 MHz)δ:22.1 (C-1),149.5 (C-2),108.1 (C-3),155.7 (C-4),157.9 (C-6),95.8 (C-7),160.3 (C-8),125.2 (C-9),148.7 (C-10),101.5 (C-11),183.8 (C-12),104.9 (C-13),160.1 (C-14),111.5 (C-15),56.9 (8-OCH3),103.7 (C-1′),74.3 (C-2′),76.7 (C-3′),70.2 (C-4′),77.5 (C-5′),61.2 (C-6′)。以上數(shù)據(jù)與文獻(xiàn)報(bào)道的數(shù)據(jù)基本一致[10],故鑒定化合物2為sporormielloside。
化合物3:淡黃色粉末。ESI-MS:m/z435 [M+H]+;1H-NMR (DMSO-d6,500 MHz)δ:13.34 (1H,s,5-OH),6.25 (1H,s,H-6),6.92 (1H,d,J=9.6 Hz,H-9),5.59 (1H,d,J=9.6 Hz,H-10),1.49 (3H,s,H-12),1.50 (3H,s,H-13),3.21 (1H,dd,J=15.6,7.3 Hz,H-14a),2.42 (1H,t,J=15.6 Hz,H-14b),3.41 (1H,dd,J=15.6 Hz,7.3 Hz,H-15),1.38 (3H,s,H-17),1.68 (3H,s,H-18),6.27 (1H,s,H-2′);13C-NMR (DMSO-d6,125 MHz)δ:160.9 (C-2),112.0 (C-3),180.9 (C-4),104.8 (C-4a),161.5 (C-5),100.1 (C-6),159.2 (C-7),101.4 (C-8),151.4 (C-8a),115.1 (C-9),127.6 (C-10),78.1 (C-11),28.4 (C-12),28.3 (C-13),19.9 (C-14),46.9 (C-15),94.1 (C-16),22.8 (C-17),28.3 (C-18),103.9 (C-1′),104.6 (C-2′),150.4 (C-3′),146.3 (C-4′),137.2 (C-5′),132.5 (C-6′)。以上數(shù)據(jù)與文獻(xiàn)報(bào)道的數(shù)據(jù)基本一致[11],故鑒定化合物3為artomandin。
化合物4:淡黃色粉末。ESI-MS:m/z421 [M+H]+;1H-NMR (DMSO-d6,500 MHz)δ:6.20 (1H,s,H-2),7.03 (1H,s,H-7),7.33 (1H,d,J=10.0 Hz,H-11),5.74 (1H,d,J=10.1 Hz,H-12),1.45 (3H,s,H-14),1.44 (3H,s,H-15),3.89 (2H,d,J=6.9 Hz,H-16),5.35 (1H,t,J=6.9 Hz,H-17),1.68 (3H,s,H-19),1.73 (3H,s,H-20),3.44 (1H,m,H-21),1.24 (3H,s,H-22),1.22 (3H,s,H-23);13C-NMR (DMSO-d6,125 MHz)δ:162.8 (C-1),98.5 (C-2),159.9 (C-3),100.7 (C-4),150.8 (C-4a),141.4 (C-5),142.5 (C-6),123.2 (C-7),132.8 (C-8),115.9 (C-8a),183.0 (C-9),103.6 (C-9a),146.6 (C-10a),115.7 (C-11),127.2 (C-12),78.2 (C-13),28.0 (C-14),28.0 (C-15),33.2 (C-16),123.9 (C-17),131.3 (C-18),25.7 (C-19),18.2 (C-20),27.2 (C-21),22.3 (C-22),22.2 (C-23)。 以上數(shù)據(jù)與文獻(xiàn)報(bào)道的數(shù)據(jù)基本一致[12],故鑒定化合物4為oliganthaxanthone A。
化合物5:淡黃色粉末。ESI-MS:m/z410 [M+H]+;1H-NMR (DMSO-d6,500 MHz)δ:6.16 (1H,s,H-2),7.17 (1H,d,J=10.0 Hz,H-11),5.74 (1H,d,J=10.0 Hz,H-12),1.45 (3H,s,H-14),1.45 (3H,s,H-15),3.97 (2H,d,J=6.3 Hz,H-16),5.18 (1H,t,J=6.0 Hz,H-17),1.61 (3H,s,H-19),1.77 (3H,s,H-20);13C-NMR (DMSO-d6,125 MHz)δ:162.6 (C-1),98.2 (C-2),159.1 (C-3),100.4 (C-4),150.7 (C-4a),130.8 (C-5),142.3 (C-6),141.5 (C-7),118.8 (C-8),109.6 (C-8a),182.1 (C-9),103.0 (C-9a),142.5 (C-10a),115.6 (C-11),126.9 (C-12),78.1 (C-13),27.9 (C-14),27.9 (C-15),24.9 (C-16),124.4 (C-17),129.6 (C-18),25.9 (C-19),18.2 (C-20)。 以上數(shù)據(jù)與文獻(xiàn)報(bào)道的數(shù)據(jù)基本一致[12],故鑒定化合物5為oliganthaxanthone B。
化合物6:淡黃色粉末。ESI-MS:m/z381 [M+H]+;1H-NMR (DMSO-d6,500 MHz)δ:7.30 (1H,dd,J=2.4 Hz,7.8 Hz,H-6),7.28 (1H,t,J=7.8 Hz,7.8 Hz,H-7),7.72 (1H,dd,J=2.4 Hz,7.8 Hz,H-8),3.51 (2H,d,J=6.8 Hz,H-1′),5.27 (1H,m,H-2′),1.85 (3H,s,H-4′),1.78 (3H,s,H-5′),6.67 (1H,dd,J=10.6 Hz,17.6 Hz,H-2″),5.34 (1H,dd,J=17.6 Hz,1.2 Hz,H-3″a),5.17 (1H,dd,J=10.6 Hz,1.2 Hz,H-3″b),1.71 (3H,s,H-4″),1.71 (3H,s,H-5″),13.52 (1H,s,OH-1);13C-NMR (DMSO-d6,125 MHz)δ:159.1 (C-1),103.1 (C-2),151.5 (C-3),105.2 (C-4),162.0 (C-4a),146.4 (C-5),119.7 (C-6),124.1 (C-7),116.5 (C-8),121.1 (C-8a),145.3 (C-8b),181.5 (C-9),114.6 (C-9a),21.7 (C-1′),123.2 (C-2′),131.5 (C-3′),18.0 (C-4′),26.1 (C-5′),41.9 (C-1″),154.3 (C-2″),106.7 (C-3″),28.2 (C-4″),28.2 (C-5″)。 以上數(shù)據(jù)與文獻(xiàn)報(bào)道的數(shù)據(jù)基本一致[13],故鑒定化合物6為pinetoxanthone。
化合物7:淡黃色粉末。ESI-MS:m/z583 [M+H]+;1H-NMR (DMSO-d6,500M)δ:6.37(1H,d,J=2.1 Hz,H-2),6.59 (1H,d,J=2.1 Hz,H-4),7.28 (1H,s,H-5),7.49 (1H,s,H-8),13.05 (1H,s,1-OH),9.88 (1H,s,7-OH),3.89 (3H,s,3-OCH3),5.45 (1H,d,J=7.6 Hz,Glc-H-1′),3.65 (1H,m,Glc-H-2′),3.54 (1H,m,Glc-H-3′),3.23 (1H,s,Glc-H-4′),3.52 (1H,m,Glc-H-5′),3.71 (2H,m,Glc-H-6′),5.23 (1H,s,Rha-H-1″),3.25 (1H,m,Rha-H-2″),3.71 (1H,m,Rha-H-3″),3.19 (1H,m,Rha-H-4″),3.83 (1H,m,Rha-H-5″),1.15 (3H,d,J=6.0 Hz,Rha-H-6″);13C-NMR (DMSO-d6,125 MHz)δ:162.4 (C-1),96.9 (C-2),165.9 (C-3),92.6 (C-4),157.4 (C-4a),145.1 (C-4b),102.7 (C-5),152.4 (C-6),150.6 (C-7),108.1 (C-8),113.6 (C-8a),103.1 (C-8b),179.4 (C-9),55.9 (3-OCH3);Glc:97.6 (C-1′),76.8 (C-2′),77.2 (C-3′),69.7 (C-4′),77.6 (C-5′),60.7 (C-6′);Rha:100.4 (C-1″),70.5 (C-2″),70.7 (C-3″),72.1 (C-4″),68.9 (C-5″),18.3 (C-6″)。以上數(shù)據(jù)與文獻(xiàn)報(bào)道的數(shù)據(jù)基本一致[14],故鑒定化合物7為polyhongkongenoside A。
化合物8:淡黃色粉末。ESI-MS:m/z319 [M+H]+;1H-NMR (DMSO-d6,500 MHz)δ:7.35 (1H,dd,J=7.9 Hz,1.6 Hz,H-6),7.28 (1H,t,J=7.9 Hz,H-7),7.76 (1H,dd,J=7.9 Hz,1.6 Hz,H-8),3.98 (3H,s,2-OCH3),4.17 (3H,s,3-OCH3),3.97 (3H,s,4-OCH3),12.69 (1H,s,1-OH),7.59 (1H,br,5-OH);13C-NMR (DMSO-d6,125 MHz)δ:151.6 (C-1),135.9 (C-2),154.3 (C-3),132.1 (C-4),144.9 (C-4a),144.9 (C-10a),145.2 (C-5),121.4 (C-6),124.5 (C-7),116.7 (C-8),120.7 (C-8a),105.0 (C-9a),181.9 (C-9),61.3 (2-OCH3),61.8 (3-OCH3),62.4 (4-OCH3)。以上數(shù)據(jù)與文獻(xiàn)報(bào)道的數(shù)據(jù)基本一致[15],故鑒定化合物8為1,5-dihydroxy-2,3,4-trimethoxyxanthone。
化合物9:淡黃色粉末。ESI-MS:m/z521 [M+H]+;1H-NMR (DMSO-d6,500 MHz)δ:13.89 (1H,s,1-OH),6.80 (1H,s,H-5),6.62 (1H,d,J=10.0 Hz,H-4′),5.72 (H,d,J=10.0 Hz,H-5′),1.45 (3H,s,H-7′),1.46 (3H,s,H-8′),3.34 (2H,d,J=7.2 Hz,H-1″),5.15 (1H,t,J=7.2 Hz,H-2″),1.62 (3H,s,H-4″),1.83 (3H,s,H-5″),4.09 (2H,d,J=7.3 Hz,H-1?),5.47 (1H,t,J=7.2 Hz,H-2?),1.65 (3H,s,H-4?),4.79 (2H,s,H-5?),2.05 (3H,s,AcO);13C-NMR (DMSO-d6,125 MHz)δ:155.1 (C-1),103.5 (C-2),156.4 (C-3),105.9 (C-4),153.1 (C-4a),100.6 (C-5),152.2 (C-6),141.4 (C-7),127.9 (C-8),109.8 (C-8a),182.1 (C-9),102.8 (C-9a),152.9 (C-10a),115.4 (C-4′),128.9 (C-5′),77.9 (C-6′),27.9 (C-7′),27.8 (C-8′),20.9 (C-1″),122.1 (C-2″),129.4 (C-3″),25.1 (C-4″),17.9 (C-5″),25.8 (C-1?),126.2 (C-2?),130.9 (C-3?),21.5 (C-4?),63.3 (C-5?),170.6 (AcO-1),21.2 (AcO-2)。 以上數(shù)據(jù)與文獻(xiàn)報(bào)道的數(shù)據(jù)基本一致[16],故鑒定化合物9為bannaxanthone I。
3.2 抑制NO產(chǎn)生作用
活性篩選表明化合物1、2、5、9可以抑制NO生成,IC50值分別為10.8、5.7、12.5、6.8 μmol·L-1。
[1] 國(guó)家藥典委員會(huì).中華人民共和國(guó)藥典:一部[S].北京:中國(guó)醫(yī)藥科技出版社,2015:89-90.
[2] 王彩君,王智民,王維皓,等.龍膽屬植物中的化學(xué)成分及藥理活性研究進(jìn)展[J].中國(guó)中藥雜志,2009,34(23):2987.
[3] 盧彥順.加味龍膽瀉肝湯治療濕熱浸淫型急性濕疹臨床研究[J].中醫(yī)學(xué)報(bào),2011,26(7):888-889.
[4] 孫毅剛.龍膽瀉肝湯加減治療肝經(jīng)郁熱型帶狀皰疹的臨床心得[J].當(dāng)代醫(yī)學(xué),2010,16(18):146-147.
[5] 鄭永新.中西醫(yī)結(jié)合分型論治多囊卵巢綜合征[J].上海中醫(yī)藥雜志,2011(1):60-62.
[6] 任小琴.中藥治療慢性盆腔炎86例[J].現(xiàn)代中西醫(yī)結(jié)合雜志,2009,18(29):3594.
[7] 楊名濱,黃愛(ài)梅.加味龍膽瀉肝湯治療慢性前列腺炎128例觀察[J].實(shí)用中醫(yī)藥雜志,2008(4):209.
[8] 吳紅躍.龍膽瀉肝湯治療復(fù)發(fā)性口腔潰瘍50例[J].中國(guó)民族民間醫(yī)藥,2011,20(2):71.
[9] Ayers S,Graf T N,Adcock A F,et al.Cytotoxic Xanthone-Anthraquinone Heterodimers from an Unidentified Fungus of the Order Hypocreales (MSX17022)[J].J Antibiot,2011,65(1):3-8.
[10]Yang B J,Chen G D,Li Y J,et al.A New Xanthone Glycoside from the Endolichenic Fungus Sporormiella irregularis[J].Molecules,2016,21(6):2-8.
[11]Gwendoline Cheng Lian Ee,Siow Hwa Teo,Mawardi Rahmani,et al.Artomandin,a new xanthone from Artocarpus kemando (Moraceae)[J].Nat Prod Res,2011,25(10):1995-2003.
[12]Tang Y X,F(xiàn)u W W,Wu R,et al.Bioassay-Guided Isolation of Prenylated Xanthone Derivatives from the Leaves of Garcinia oligantha[J].J Nat Prod,2016,79(7):1752-1761.
[13]Alarcon A B,Cuesta-Rubio OPerez J C,Piccinelli A L,et al.Constituents of the Cuban endemic species Calophyllum pinetorum[J].J Nat Prod,2008,71(7):1283-1286.
[14]Wu J F,Chen S B,Gao J C,et al.Xanthone glycosides from herbs of Polygala hongkongensis Hemsl and their antioxidant activities[J].J Asian Nat Prod Res,2008,10(7-8):673-678.
[15]Sun Y W,Sun Z H,Yu P Z.A new xanthone from Halenia elliptica D.Don.[J].J Asian Nat Prod Res,2011,13(13):88-92.
[16]Na Z,Xu Y K.A new prenylated xanthone from Garcinia xipshuanbannaensis Y.H.Li.[J].Nat Prod Res,2010,24(17):1648-1653.
XanthoneConstituentsfromRootandRhizomeofGentianamanshurica
ZHOU Yanli,ZHANGYan*,LIYingqin,WANGAili,LIShuoxi,LIBoqian
(JiamusiCollege,HeilongjiangUniversityofChineseMedicine,Jiamusi154007,China)
Objective:To isolate and identify chemical constituents from the roots and rhizomes ofGentianamanshurica.Methods:The xanthone constituents were isolated by column chromatography and their structures were elucidated through ESI-MS and NMR.Results:Nine compounds were isolated from the plant,and identified as acremoxanthone D (1),sporormielloside (2),artomandin (3),oliganthaxanthone A (4),oliganthaxanthone B (5),pinetoxanthone (6),polyhongkongenoside A (7),1,5-dihydroxy-2,3,4-trimethoxyxanthone (8),and bannaxanthone I (9).Compounds1,2,5,and9showed the inhibitory activity against lipopolysaccharide-induced nitric oxide production in C57BL6/J mouse macrophage cells,with IC50values of 10.8,5.7,12.5 and 6.8 μmol·L-1,respectively.Conclusion:Compounds1-9were obtained fromGentianafor the first time.
GentianamanshuricaKitag;xanthone;anti-inflammatory activity
國(guó)家自然基金項(xiàng)目 (31471923,31172009);黑龍江中醫(yī)藥大學(xué)?;痦?xiàng)目(201736)
] 張艷,講師,研究方向:中草藥微量活性成分;Tel:(0545) 6103257,E-mail:tonyyan20081982@163.com
10.13313/j.issn.1673-4890.2017.7.011
2016-11-13)
*[